Search PepX: proto-oncogene
24 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1ABO | CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE | C | A | SH3-like barrel |
 |
  |
1FYN | PHOSPHOTRANSFERASE | B | A | SH3-like barrel |
|
  |
2VP7 | DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX | B | A |
|
|
  |
2VPB | DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX | B | A |
|
|
  |
2VPE | DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX | D | C |
|
|
  |
2VPG | DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX | B | A |
|
|
  |
2WAX | STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3-FDF PEPTIDE | B | A |
|
|
  |
2WAY | STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3-FDF PEPTIDE | B | A |
|
|
  |
3BEJ | Structure of human FXR in complex with MFA-1 and co-activator peptide | E | A | Nuclear receptor ligand-binding domain |
|
  |
3BQD | Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol | B | A | Nuclear receptor ligand-binding domain |
|
  |
3CBL | Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide | B | A |
|
|
  |
3CD3 | Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide | B | A |
|
|
  |
3CXW | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I | B | A |
|
|
  |
3CY2 | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand II | B | A |
|
|
  |
3CY3 | Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and the JNK inhibitor V | B | A |
|
|
  |
3DCT | FXR with SRC1 and GW4064 | B | A | Nuclear receptor ligand-binding domain |
|
  |
3EQS | Crystal structure of human MDM2 in complex with a 12-mer peptide inhibitor | B | A |
|
|
  |
3ET1 | Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3ET3 | Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3FXV | Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist | B | A |
|
|
  |
3G03 | Structure of human MDM2 in complex with high affinity peptide | B | ACD |
|
|
  |
3G8I | Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | Z | A |
|
|
  |
3G9E | Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | B | A |
|
|
  |
3H0A | Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist | B | A |
|
